CNBC's Rick Santelli discusses bond prices and yields.
Restaurateur Joe Bastianich discusses his decision to open another Eataly, a massive Italian marketplace at the new World Trade Center.
CNBC's Courtney Reagan reports on the growing retail presence in New York City's revived financial district.
CNBC's Meg Tirrell on a Wall Street Journal report that Mylan tied executive pay to aggressive profit targets.
CNBC's Steve Liesman looks ahead to tomorrow's big jobs number and discusses the magic number that could convince the Fed to raise rates in September.
CNBC's Meg Tirrell and Charles Elson, University of Delaware, discuss a Wall Street Journal report that Mylan tied executive pay to aggressive profit targets.
Apple CEO Tim Cook has taken to the airwaves in Ireland to make his feelings known about the company's $14.5 billion tax bill. CNBC's Jon Fortt and Jim Pethokoukis discuss.
CNBC's Morgan Brennan reports on Elon Musk's response to this morning's explosion.
CNBC's Phil LeBeau and Bob Lutz, former vice chairman of GM, discuss Tesla's tough week and the auto business in general.
CNBC's Phil LeBeau reports on problems at Tesla and now SpaceX, after a rocket launch failed in spectacular fashion today.
CNBC's Morgan Brennan reports on what went wrong during a SpaceX launch that caused a rocket to explode, live from Cape Canaveral, Florida.
Trump scored big with that one-two punch of his trip to Mexico followed by a fiery immigration speech.
A daily morning look at the financial stories you need to know to start the day.
Trump just got a presidential-looking shot in the arm from perhaps the one foreign leader we least expected to give it to him, says Jake Novak — Mexico's president.
Gold has struggled this summer, but one portfolio manager has a way to trade the metal in today's flat market.
Certain technical indicators suggest that there may be some moves to the downside in the short term.
Joseph LaVorgna said that the chances the Fed will raise interest rates in September could be 60 percent on a strong jobs report.
Paul Ross, Edrington Americas, talks about the brand new Macallan 12-year-old double cask single malt.
CNBC's Meg Tirrell and Hans Bishop, CEO of Juno Therapeutics, discuss the future of the immunotherapy space.
CNBC's Meg Tirrell on why these two stocks are taking such a beating today.